Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study - Concepedia

Concepedia

Publication | Open Access

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

DOI Full Paper Access

185

Citations

22

References

2019

Year

Rina Hui, Mustafa Özgüroğlu, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit,

The Lancet Oncology

Abstract

AstraZeneca.

References

	Year	Citations

Page 1